Last reviewed · How we verify
Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Infanrix | infanrix | Pfizer | vaccine |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years:
- Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years treatment updates — RSS
- Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years treatment updates — Atom
- Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years treatment updates — JSON
Cite this brief
Drug Landscape (2026). Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-diphtheria-tetanus-and-pertussis-in-infants-and-children-aged-6-weeks-through-6-years. Accessed 2026-06-10.
Related
- Prevention of diphtheria, tetanus, and pertussis in infants and children aged 6 weeks through 6 years full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing